Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
NCT03295981Phase 3Recruiting
- Sponsor
- Saint Louis University
- Start
- May 2018
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised trial of zoledronic acid in Giant Cell Tumor of Bone (GCTB) (2 arms), sponsored by Saint Louis University. Primary endpoint: Local recurrence rate at 2 years. Started May 2018; status: recruiting.
02
Drugs
zoledronic acid
03
Conditions
Giant Cell Tumor of Bone (GCTB)
Beyond the preview
Go deeper on NCT03295981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03295981.